Eli Lilly touts long-term safety data for Olumiant amid classwide scrutiny on JAK meds
Eli Lilly touts long-term safety data for Olumiant amid classwide [...]
Eli Lilly touts long-term safety data for Olumiant amid classwide [...]
AstraZeneca creates unit to handle its COVID-19 vaccines and antibody [...]
Samsung Pharm hit with 3-month production suspension from Korean regulators [...]
Lilly and Boehringer’s Jardiance shows benefits for those with ‘intimately [...]
Bristol Myers Squibb’s Opdivo posts another win in early lung [...]
With oncology spinoff done, bluebird bio moves to new digs [...]
GlaxoSmithKline’s novel anemia drug succeeds where AstraZeneca-FibroGen, Akebia failed aliu [...]
Endo uses carrots for Xiaflex ad launch to show the [...]
Emergent loses out on $180M as U.S. cancels COVID-19 vaccine [...]
Democrats’ drug pricing deal is ‘not a bad outcome’ for [...]